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ABSTRACT 
Safety is the major concern today. It mainly depends on the method of preparation. To assess the quality 
of a finished product, there should be some basic standards as well as methods of preparation. 
Shashilekha Vati is one such Herbo-mineral compound used in the treatment of Vitiligo. A chronic 
Toxicity Study for Shashilekha Vati carried out in the National Toxicology Centre (N.T.C.) Pune to 
establish the tolerability and to evaluate the effective and non-toxic human dose of Shashilekha Vati by 
assessing the histopathological and subjective changes in animals. Young (6-8 wks old) male and female 
Swiss albino mice (28-32 gms of weight), bred at the N.T.C. were used for the study. The duration of the 
chronic toxicity study was of 3 months (90 days). Shashilekha Vati was prepared according to the 
method mentioned in the classical text of Yogaratnakara. During the course of the study, all the animal 
belonging to the entire different groups were observed for food intake, signs of toxicity, histo-
pathological study. Clinical parameters (food intake, body weight, sings of Toxicity) indicate safety of 
Shashilekha Vati for Human Dose Group. Histological findings for day 90; for Ten Times Human Dose 
Group showed degenerative changes in the liver and kidneys. While it shows mild to moderate 
degenerative changes in Ten Times Human Dose. The study showed positive results as the Shashilekha 
Vati is safe and non toxic when given in human dose. 
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INTRODUCTION 
Ayurvedic practice involves the use of 
medications that typically contain herbs, metals, 
minerals or other materials. Health officials in India 
and other countries have taken steps to address some 
concerns about these medications. Concerns relate to 
toxicity, formulations, interactions, and scientific 
evidence. Ayurvedic medications have the potential to 
be toxic. Many materials used in them have not been 
thoroughly studied in either Western or Indian 
research. Most clinical trials (i.e., studies in people) of 
Ayurvedic approaches have been small, had problems 
with research designs, lacked appropriate control 
groups, or had other issues that affected how 
meaningful the results were.[2] Therefore, scientific 
evidence for the effectiveness of Ayurvedic practices 
varies, and more rigorous research is needed to 
determine which practices are safe and effective. 
These are the challenges which you have to face or 
questions you should have in mind before planning any 
clinical trial for Ayurvedic and traditional medicines. 
However, improper processing/manufacturing of 
Ayurvedic medicines may result into severe toxicity[4]. 
Recently, heavy metal contamination was also reported 
in some Ayurvedic medicines sold in USA.[5] This raised 
concerns regarding safety of such products for human 
use as medicines.[6] A chronic Toxicity Study for 
Shashilekha Vati carried out in the National Toxicology 
Centre (N.T.C.), Pune. 
A) Need for Toxicity study 
- To establish the tolerability of Shashilekha Vati. 
- To evaluate the effective and non-toxic human dose 
of Shashilekha Vati. 
- To assess the histopathological and subjective 
changes in animals. 
- To establish the safety of human subjects as per 
OECD (Organization for economic and commercial 
Development). 
B) Methodology 
A) Preparation of study Drug (Shashilekha Vati)[1] 
 Shashilekha Vati was prepared according to the 
method mentioned in the classical text of 
Yogartnakara. 
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 Shuddha Parada (Mercury) and Shuddha Gandhaka 
(Sulphur) in equal preparations were thoroughly 
mixed and made into Kajjali. 
 Kajjali was mixed with Shuddha Tamra Bhasma 
taken in equal proportion. 
 Bakuchi Kvatha (decoction of Psoralia corylifolia) 
was also mixed with the above mentioned 
ingredients and grinding for about 24 hours.  
 This mixture was then dried in a heater. 
 This dried mixture was then passed through a 
sieve to get granules.  
 These granules were then loaded in the tablet-
making machine to make tables of 1 Gunja (125 
mg) each. (Table 1) 
Table 1: Ingredients of Shashilekha Vati 
Shashilekha Vati 
Ingredients Shuddha 
Parada 
Shuddha 
Gandhaka 
Tamra 
Bhasma 
Proportion 1 part 1 part 1 part 
Mardana with Bakuchi kvatha 
Preparation of Study animals 
- Young (6-8 wks old) male and female Swiss albino 
mice (28-32 grams of weight), bred at the N.T.C. 
were used for the Study. 
- The animals were housed in polypropylene cages 
with paddy husk as feeding at a temperature of 
24-260C and a relative humidity of 30-70%. A 12: 
12 light dark circle was followed. 
- All animals had free access to filtered water and a 
standard polluted laboratory animal diet was 
given as food to the animals. 
All the experimental procedure / Protocols used in this 
study were in accordance with the guidelines of the 
Committee for the purpose of control and supervision 
of experiments on Animals (CPCSEA). 
Experimental protocol 
- The numbers of animals used in the study were 18 
(9 males and 9 females) 
- These animals were divided into three different 
groups namely : 
1. Control Group 
2.  Human dose group 
3. Ten times human dose group 
- Each group contained 3 male and 3 Female 
animals 
- The duration of the chronic toxicity study was of 3 
months (90 days). 
 (This was because any long-term treatment in man is 
to be preceded by 3-12 months of chronic toxicity 
studies in animals as per the prescribed 
guidelines). 
- Calculations for doses administered were based 
on standard conversion constant (0.0026 times 
Human Dose) related to Swiss albino mice. 
Dose in mice  = 0.0026 x 425 mg/day. 
    = 1.105 mg/day 
Thus, each animal received the following dose everyday 
through a gastric tube. (2 ml syringe with a 14 no. 
needle curved at an angle of 130). (Table 2) 
Table 2: Drug dose animal received everyday through a gastric tube
Groups Dose per animal per day 
a) Control group 0.2 ml distilled water 
b) Human dose group 1.105 mg Shashilekha Vati dissolved in Bakuchi taila and Madhu 
c) Ten times human dose group  11.05 mg Shashilekha Vati dissolved in Bakuchi taila and Madhu 
During the course of the study, body weight and food 
Intake were measured at regular intervals of every 
seven days. 
- Also after dosing all the animals were observed for 
toxicity signs and mortality. 
- On the 90th day of the study, all animals were 
sacrificed by cervical dislocation. 
- Autopsy was performed on these animals with their 
vital organs like liver and kidney being examined for 
gross changes as well as for any histological changes 
Observation 
- During the course of the study, all the animal 
belonging to the entire different group were 
observed for the following parameters. 
 
i) Food Intake 
- 50 grams of standard polluted laboratory animal 
diet was kept as food every day, in one cage 
containing 3 animals. 
-  The food intake per animal was calculated every 7 
days in the following way:  
Food given (in grams) - Food remaining (in grams) x 3 
= Food consumed. 
ii) Body Weight 
- Body weight (in grams) for each and every animal 
was taken at an interval of every seven days. 
- The animals were individually weighed on a 
standard weighing scale. 
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iii) Signs of Toxicity 
All the animals belonging to the different groups were 
observed every day for the following signs of toxicity:- 
 Ataxia   
 Excessive Lacrimation 
 Convulsions  
 Tremors 
 Diarrhoea  
 Abnormal micturition 
 Excessive salivation   
iv) Histo Patholgical study 
- The histo pathological study of the vital organs 
like, the liver and the kidneys of all the animals 
(No.1 to N.18) were done at Pradhan Surgical 
Pathology Laboratory, Pune. 
Table 3: Food Consumption Data (In grams) for Control Group Mice 
Mice No. Sex Day Day Day Day Day Day Day Day Day Day Day Day Day Day 
  0 7 14 21 28 35 42 49 56 63 70 77 84 90 
1 M 2.66 16.66 12 10 9.33 6.66 6.66 6.66 7.33 7.33 9.33 9.33 8.66 9.33 
2 M 2.66 16.66 12 10 9.33 6.66 6.66 6.66 7.33 7.33 9.33 9.33 8.66 9.33 
3 M 2.66 16.66 12 10 9.33 6.66 6.66 6.66 7.33 7.33 9.33 9.33 8.66 9.33 
4 F 2.66 11.33 10.66 8.66 7.33 4.66 4.66 4.66 5.33 4.66 7.33 6.66 7 7.33 
5 F 2.66 11.33 10.66 8.66 7.33 4.66 4.66 4.66 5.33 4.66 7.33 6.66 7 7.33 
6 F 2.66 11.33 10.66 8.66 7.33 4.66 4.66 4.66 5.33 4.66 7.33 6.66 7 7.33 
Table 4: Food Consumption Data (In grams) for Human Dose Group Mice 
Mice No. Sex Day Day Day Day Day Day Day Day Day Day Day Day Day Day 
  0 7 14 21 28 35 42 49 56 63 70 77 84 90 
7 M 2.66 14 8 7.33 7.33 5.33 7.33 7.33 6.66 6.66 7.33 7.33 6.66 5.33 
8 M 2.66 14 8 7.33 7.33 5.33 7.33 7.33 6.66 6.66 7.33 7.33 6.66 5.33 
9 M 2.66 14 8 7.33 7.33 5.33 7.33 7.33 6.66 6.66 7.33 7.33 6.66 5.33 
10 F 1.33 11.33 8 8.66 7.33 4 4.66 4.66 4.66 4.66 5.33 5.33 4.66 4.66 
11 F 1.33 11.33 8 8.66 7.33 4 4.66 4.66 4.66 4.66 5.33 5.33 4.66 4.66 
12 F 1.33 11.33 8 8.66 7.33 4 4.66 4.66 4.66 4.66 5.33 5.33 4.66 4.66 
Table 5: Food Consumption Data (In grams) for Ten Times Human Dose Group Mice 
Mice No. Sex Day Day Day Day Day Day Day Day Day Day Day Day Day Day 
  0 7 14 21 28 35 42 49 56 63 70 77 84 90 
13 M 0.66 8 6 5.33 4.66 3.33 7 7 8 7 6.66 7 6.66 5.33 
14 M 0.66 8 6 5.33 4.66 3.33 7 7 8 7 6.66 7 6.66 5.33 
15 M 0.66 8 6 5.33 4.66 FD FD FD FD FD FD FD FD FD 
16 F 0 4.66 7.33 6.66 4.66 3.33 4 4.66 4.66 4.66 5.33 4.66 5.33 5.33 
17 F 0 4.66 7.33 6.66 4.66 3.33 4 4.66 4.66 4.66 5.33 4.66 5.33 5.33 
18 F 0 4.66 7.33 6.66 4.66 3.33 4 4.66 4.66 4.66 5.33 4.66 5.33 5.33 
FD = Found dead; Note: Animal no. 15 was found dead on day35. 
Table 6: Body Weight Data (In grams) for Control Group Mice 
Mice no Sex Day Day Day Day Day Day Day Day Day Day Day Day Day Day 
  0 7 14 21 28 35 42 49 56 63 70 77 84 90 
1 M 36 40 44 46 48 50 50 50 50 50 50 50 50 50 
2 M 34 36 40 42 44 46 46 46 48 50 50 50 50 50 
3 M 36 38 40 44 46 48 48 50 50 52 52 52 52 54 
4 F 32 34 36 38 38 40 40 40 40 42 42 42 42 44 
5 F 28 28 30 34 34 34 36 38 36 40 40 40 40 42 
6 F 32 34 38 40 40 40 42 44 42 44 44 44 44 44 
Table 7: Body Weight Data (In grams) for Human Dose Group Mice 
Mice No. Sex Day Day Day Day Day Day Day Day Day Day Day Day Day Day 
  0 7 14 21 28 35 42 49 56 63 70 77 84 90 
7 M 36 38 38 40 40 40 44 46 44 46 48 50 50 52 
8 M 30 32 32 34 34 34 36 38 38 40 42 44 46 48 
9 M 30 32 32 34 34 36 36 34 36 38 40 44 46 48 
10 F 28 30 30 32 34 34 34 34 34 34 34 34 34 40 
11 F 28 26 30 32 34 36 34 34 36 38 38 40 40 42 
12 F 28 30 30 30 30 32 36 36 32 36 36 36 36 38 
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Table 8: Body Weight Data (In grams) For Ten Times Human Dose Group Mice 
Mice no Sex Day Day Day Day Day Day Day Day Day Day Day Day Day Day 
  0 7 14 21 28 35 42 49 56 63 70 77 84 90 
13 M 36 32 30 34 34 36 36 34 36 34 34 34 34 36 
14 M 34 28 26 28 28 30 30 30 30 30 30 30 30 40 
15 M 30 26 24 26 24 22 FD FD FD FD FD FD FD FD 
16 F 32 26 24 26 28 30 30 34 30 34 34 36 36 40 
17 F 28 30 28 32 32 34 34 36 34 36 36 38 38 42 
18 F 28 28 30 34 36 36 36 38 36 38 38 40 40 40 
FD = Found dead Note: Animal no. 15 was found dead on day 35. 
Sings of Toxicity for Control Group Mice 
 After administering the prescribed doses the animals (No.1 to No 6) appeared normal and showed no 
clinical signs of toxicity such as ataxia, convulsions, diarrhoea, excessive salivation, lacrimation, tremors, abnormal 
micturation, death etc. till the end of the study (90 days). 
Sings of Toxicity for Control Group Mice 
 After administering the prescribed doses the animals (No.7 to No 12) appeared normal and showed no 
clinical signs of toxicity such as ataxia, convulsions, diarrhoea, excessive salivation, lacrimation, tremors, abnormal 
micturation, death etc. till the end of the study (90 days). The only observation made was that the animals belonging 
to this group passed black coloured stool during the course of the study. 
Sings of Toxicity for Ten Times Human Dose Group Mice 
 After administering the prescribed doses the animals (No.13 to No 18) appeared normal and showed no 
clinical signs of toxicity such as ataxia, convulsions, diarrhoea, excessive salivation, lacrimation, tremors, abnormal 
micturation. 
 The observation made was that the animals belonging to this group passed black coloured Stool during the 
course of the study, (90 days) Also animal No 15, was found dead on Day 35. 
Table 9: Histopathological Report of Animals Sacrificed On  
S. No. Group Animal no. Sex Liver 
1 Control 1 M NAD 
2 Control 2 M NAD 
3 Control 3 M NAD 
4 Control 4 F NAD 
5 Control 5 F NAD 
6 Control 6 F NAD 
7 Human dose 7 M Mild regenerative activity 
8 Human dose 8 M Mild regenerative activity vacuolated nuclei 
9 Human dose 9 M Sinusoidal congestion 
10 Human dose 10 F Sparse sinusoidal lymphocytes vacuolated nuclei 
11 Human dose 11 F Sinusoidal congestion and mononuclear cells. Few 
collections of mononuclear cells in lobules 
12 Human dose 12 F Sinusoidal congestion and mononuclear cells and few 
collections of mononuclear cells in lobules and chuffer’s 
cell hyperplasia 
13 Ten times human dose 13 M Sinusoidal congestion and mononuclear cells and few 
collections of mononuclear cells in lobules and chuffer’s 
cell hyperplasia 
14 Ten times human dose 14 M Sinusoidal congestion and mononuclear cells chuffer’s 
cell hyperplasia 
15 Ten times human dose 16 F Congestion, sinusoidal mononuclear cells, vacuolated 
cells, pan lobular necrosis 
16 Ten times human dose 17 F Focal mononuclear cells. Focal liver cell necrosis 
17 Ten times human dose 18 F Focal liver cells necrosis and congestion 
NAD:-No abnormality detected. 
 
Int. J. Ayur. Pharma Research, 2015;3(8):95-100 
 IJAPR | August 2015 | Vol 3 | Issue 8   99 
Table 10: Histopathological Report of Animals Sacrificed on Day 90 
S.No Group Animal no. Sex Kidneys 
1 Control 1 M NAD 
2 Control 2 M NAD 
3 Control 3 M NAD 
4 Control 4 F NAD 
5 Control 5 F NAD 
6 Control 6 F NAD 
7 Human dose 7 M NAD 
8 Human dose 8 M NAD 
9 Human dose 9 M NAD 
10 Human dose 10 F NAD 
11 Human dose 11 F NAD 
12 Human dose 12 F NAD 
13 Ten times human dose 13 M NAD 
14 Ten times human dose 14 M NAD 
15 Ten times human dose 16 F Cloudy focal changes and tubular necrosis 
16 Ten times human dose 17 F Cloudy focal changes and tubular necrosis 
17 Ten times human dose 18 F Cloudy focal change and tubular necrosis casts intubules 
NAD:-No abnormality detected. 
Table 11: Blood Chemistry Data of Control Group Mice Sacrificed On Day 90 
S. No. Animal No. SEX BSL SGPT AP BUN TP 
1 1 M 98 36 28 20 5.8 
2 2 M 96 38 26 24 5.6 
3 3 M 102 37 24 22 5.9 
4 4 F 104 38 26 20 5.6 
5 5 F 98 37 28 20 5.4 
6 6 F 102 35 22 22 5.2 
7 7 M 98 38 26 22 5.9 
8 8 M 104 35 26 20 5.6 
9 9 M 100 36 24 24 5.4 
10 10 F 96 38 24 24 5.4 
11 11 F 98 35 22 20 5.0 
12 12 F 104 36 26 22 5.2 
13 13 M 98 42 27 29 5.6 
14 14 M 94 40 24 29 5.8 
15 16 F 98 39 26 29 5.0 
16 17 F 102 42 24 27 5.2 
17 18 F 100 40 26 27 5.0 
BSL: Blood sugar level in mg\100ml. 
SGPT: Serum glutei pyretic transaminase in u\l 
AP: Alkaline phosphate in U\l. 
BUN: Blood Urea Nitrogen in mg\100ml. 
TP: Total protein in g\100ml. 
Result 
i)  Food Intake 
- The food intake in the control group had gradually 
increased upto 90 days. 
- The food intake in the Human Dose Group and 
Ten Times Human Dose Group had significantly 
reduced during the course of 90 days. 
ii) Body Weight 
- Statistically significant changes in weight were 
seen in the Animals belonging to Human Dose 
Group and Ten Times Human Dose Group. 
- Thus, the groups that received Shashilekha Vati at 
Human Dose and Ten Times Human Dose showed 
less increase in the weight than the animals 
belonging to Control Group. 
Histopathology study 
- The results of the histopathology study was that 
the animalsNo.1 to 6 (Control Group) did not 
showed any abnormality in liver and no changes in 
kidneys. 
- Animals No.7 to 13 (Human Dose Group) showed 
mild degenerative activity, sinusoidal congestion 
and collection of mononuclear cells in lobules of 
liver and no changes in kidneys. 
- Animals No.14 to 18 (Ten Times Human Dose 
Group) showed sinusoidal congestion, focal liver 
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cell necrosis in liver and cloudy focal changes and 
tubular necrosis in kidneys. 
CONCLUSION 
Clinical parameters (food intake, body weight, sings of 
Toxicity) indicate safety of Shashilekha Vati for Human 
Dose Group. 
Histological findings for day 90; for Ten Times Human 
Dose Group showed degenerative changes in the liver 
and kidneys. Thus, overall Shashilekha Vati is safe at 
Human Dose.  
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